Drawing for AG-MARK

USPTO serial 78137083

AG-MARK

Reviewed by CopyMark Law Group

Reg. 2773587Status 710
Filing date
Status date
Registration date
Oct 14, 2003
Examiner
WOOD, CAROLINE
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with AG-MARK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James A. Napier

JAMES A NAPIER BROWN, WINICK, GRAVES, GROS, BASKERVILLE666 GRAND AVE STE 2000DES MOINES, IA 50309UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Topical Medication for Livestock for use in the treatment especially of brucellosis, leptospirosis, pasteurellosis, salmonellosis, trichinosis, eastern equine encephalomyelitis, rabies and rabies related infections, and lyssaencelphalitis, but also of anthrax, borreliosis, campylobacies ententis, capmocylophaya infection, cat scratch fever, clostridiaal diseases, coliform diseases, erysipcloid, glanders, leprosy, listeriosis, meliodisis, mycobateriosis, plague, psittacosis and ormithosis, rat bite fever, streptococcal infections, tetanus, tuberculosis, tularemia, vibrio food infection, yersimiosis, boutonneuse fever, ehrlichiosis sennetsu fever, murine typhyus, north Asian tick-born rickettsiosis, Q fever, Queensland tick typhus, rickettsial pox, Rocky Mountain spotted fever, scrub typhus, typhus, actionomycosis, aspergillosis, blastomycosis, candidiasis, coccidoidonnycosis, cryptococcosis, dermatophilosis, histoplasmosis, nocardiosis, rhinosporidisis, ringworm, sporotrichosis, babesiosis, balantidiasis, chagas' disease, cryptosporidiosis, giardiasis, leishmaniasis, malaria, pneumoeystis pneumonia, sarcocystosis, toxoplasmosis, trypanosomiasis, clonorochiasis, dicrocoeliasis, echinostomiasis, fascioliosis, fasciolopsiasis, gastrodiscoidiasis, heterophyiasis, metagonimiasis, nanophyetiasis, opisthorchiasis, paragonimiasis, schistosomiasis, swimmer's itch, bertielliasis, coenuriasis, diphyilobothriasis, dipylidiasis, echinococcosis, hymenolepiasis, inermicapsifer infection, mouse or rat tapeworm, pork tapeworm disease, Asian taeniasis, raillietina infection, sparganosis, taeniasis and cysticercosis, angiostrongliasis, anisakiasis, capillariasis, dioctophymosis, dracunculiasis, filariasis, grathostomiasis, gongylonemiasis, larva migrans-cutaneous, larva migrans; visceral, oesophagostomiasis, ternidensiasis, strongyloidiasis, thelaziasis, trichostrongytiasis, trichuriasis, macracanthorhynchosis, hirundiniasis, acariasis, myiasis, pentastomid infections, tick paralysis, tunga infections, african hemorrhagic fever, filovirus infections, Argentinean hemorrhagic fever, Bolivian hemorrhagic fever, Brazilian hemorrhagic fever, central European tick-borne encephalitis, Colorado tick fever, contagious ecthyma, cowpox, Crimean-congo hemorrhagic fever, encephalomyocarditis, far eastern tick-borne encephalitis, foot-and-mouth disease, hantaviral diseases, hemorrhagic fever with renal syndrome, simian herpes b virus disease, influenza, including type a Japanese b encephalitis, kyasanur forest disease, lassa fever, louping ill, lymphocytic choriomeningitis, milker's nodules, monkeypox, murray valley encephalitis, Newcastle disease, omsk hemorrhagic fever, rift valley fever, St Louis encephalitis, sindbis virus disease, ross river disease, tanaopx, Venezuelan hemorrhagic fever, Venezuelan equine encephalomyelitis, vesicular stomatitis, wesslesbron fever, west Nile fever, western equine encephalomyelitis, yabapox, and yellow fever; vitamin-mineral premixes for animal feedsSECTION 8 - CANCELLEDMar 14, 1978

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 22, 2010C8..CANCELLED SEC. 8 (6-YR)
Feb 18, 2010ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jul 30, 2008CFITCASE FILE IN TICRS
Mar 19, 2008ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 14, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 22, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 2, 2003NPUBNOTICE OF PUBLICATION
May 23, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 17, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 17, 2003TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 17, 2002GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 10, 2002DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance